Sepideh Abdi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sepideh Abdi has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Negar Taheri
Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Ali Qandian
Communicable Disease Office, Health Affairs, Qazvin University of Medical Sciences, Qazvin, Iran
1 shared publication Alyaa Al-Ibraheemi
From the Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215 (S.A., A.K., J.C., S.D., J.S.W.); Department of Pathology, Boston Children's Hospital, Boston, Mass (A.A.I.); and Department of Radiology, Division of Musculoskeletal Imaging and Intervention (S.E.S., J.S.W.), and STRATUS Center for Simulation in Medical Education (S.E.S.), Brigham and Women's Hospital, Harvard Medical School, Boston, Mass
1 shared publication- Aparna Komarraju
From the Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215 (S.A., A.K., J.C., S.D., J.S.W.); Department of Pathology, Boston Children's Hospital, Boston, Mass (A.A.I.); and Department of Radiology, Division of Musculoskeletal Imaging and Intervention (S.E.S., J.S.W.), and STRATUS Center for Simulation in Medical Education (S.E.S.), Brigham and Women's Hospital, Harvard Medical School, Boston, Mass
1 shared publication - Arad Iranmehr
Department of Neurosurgery, Sina Hospital Tehran University of Medical Sciences Tehran Iran
1 shared publication - Behrooz Hassani
Iran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 24 April 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (4) , e1005032
Tobacco control policies on cancer prevention in the Eastern Mediterranean Region, 2025–2050: A modeling study
Background: Despite the implementation of control policies, smoking prevalence remains high in Eastern Mediterranean Region (EMR), and the impact of tobacco control efforts on cancer prevention is unclear. We assessed the potential impact of key policy interventions on tobacco-related cancer incidence in EMR countries from 2025 to 2050. Methods and findings: We conducted a modeling study using a country-level historical data to project tobacco smoking prevalence in EMR countries under four scenarios: (i) full implementation of the MPOWER (Monitor, Protection, Offer, Warn, Enforce, and Raise) policy package, (ii) a 10-unit increase in the cigarette affordability index (Higher values of the affordability index indicate that cigarettes are less affordable) (iii) maximized literacy rates (100% adult literacy), and (iv) combined implementation of all three policies. For each scenario, we estimated the Population Attributable Fraction (PAF) of tobacco smoking for 13 cancer types causally linked to tobacco use. The number of preventable cancer cases was calculated using the difference in PAFs between the current and alternative scenarios, referred to as the Potential Impact Fraction (PIF). An estimated 14.3 million tobacco-related cancer cases will occur in the EMR between 2025 and 2050, with over 3 million attributable to current smoking prevalence (PAF = 21.3%; [95% CI: 18.4, 24.6]). Combined implementation of all assessed policies could prevent 442,292 cases (95% CI: 226,987, 660,045) (3.1% of all projected cases; [95% CI: 1.6, 4.6]). The greatest impact was observed in low HDI (Human Development Index) countries, where up to 291,425 (95% CI: 198,186, 388,546) cases could be averted. Maximizing literacy showed the highest preventive potential in low ( n = 224,463; [95% CI: 149,521, 307,386]) and medium HDI ( n = 84,569; [95% CI: [2,801, 177,317]) countries, while full implementation of MPOWER had the greatest effect in high HDI countries ( n = 11,890; [95% CI: 8,397, 15,378]). As our main limitation, we assumed a causal relationship between previously implemented policies and concurrent changes, while other potential causes of these changes have not been considered in the current study. Conclusion: Strengthening tobacco control policies particularly improving literacy in low HDI countries may potentially contribute to reductions in future cancer burden in EMR.
- 24 April 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (4) , e1005032
Open AccessTobacco control policies on cancer prevention in the Eastern Mediterranean Region, 2025–2050: A modeling study
Background: Despite the implementation of control policies, smoking prevalence remains high in Eastern Mediterranean Region (EMR), and the impact of tobacco control efforts on cancer prevention is unclear. We assessed the potential impact of key policy interventions on tobacco-related cancer incidence in EMR countries from 2025 to 2050. Methods and findings: We conducted a modeling study using a country-level historical data to project tobacco smoking prevalence in EMR countries under four scenarios: (i) full implementation of the MPOWER (Monitor, Protection, Offer, Warn, Enforce, and Raise) policy package, (ii) a 10-unit increase in the cigarette affordability index (Higher values of the affordability index indicate that cigarettes are less affordable) (iii) maximized literacy rates (100% adult literacy), and (iv) combined implementation of all three policies. For each scenario, we estimated the Population Attributable Fraction (PAF) of tobacco smoking for 13 cancer types causally linked to tobacco use. The number of preventable cancer cases was calculated using the difference in PAFs between the current and alternative scenarios, referred to as the Potential Impact Fraction (PIF). An estimated 14.3 million tobacco-related cancer cases will occur in the EMR between 2025 and 2050, with over 3 million attributable to current smoking prevalence (PAF = 21.3%; [95% CI: 18.4, 24.6]). Combined implementation of all assessed policies could prevent 442,292 cases (95% CI: 226,987, 660,045) (3.1% of all projected cases; [95% CI: 1.6, 4.6]). The greatest impact was observed in low HDI (Human Development Index) countries, where up to 291,425 (95% CI: 198,186, 388,546) cases could be averted. Maximizing literacy showed the highest preventive potential in low ( n = 224,463; [95% CI: 149,521, 307,386]) and medium HDI ( n = 84,569; [95% CI: [2,801, 177,317]) countries, while full implementation of MPOWER had the greatest effect in high HDI countries ( n = 11,890; [95% CI: 8,397, 15,378]). As our main limitation, we assumed a causal relationship between previously implemented policies and concurrent changes, while other potential causes of these changes have not been considered in the current study. Conclusion: Strengthening tobacco control policies particularly improving literacy in low HDI countries may potentially contribute to reductions in future cancer burden in EMR.
- Open Access
- 8 April 2026
- Published by Springer Nature in NPP—Digital Psychiatry and Neuroscience
- Vol. 4 (1) , 7
Advancing neurotech justice in youth digital mental health: insights from an interdisciplinary and cross-generational workshop
Researchers and clinicians are increasingly looking to leverage artificial intelligence (AI) and digital tools to improve psychiatric care. Of particular promise is addressing the youth mental health crisis. Yet, the introduction of AI-enabled digital technologies for psychiatric treatment of young adults raises a host of ethical, legal, and societal issues (ELSI). To provide guidance in addressing these issues, we convened a two-day meeting at the Radcliffe Institute for Advanced Study at Harvard University: Advancing Neurotech Justice in Mental Health: Insights from an Interdisciplinary and Cross-Generational Workshop . The meeting brought together a diverse cohort of 17 experts and 5 students from various fields and different countries. In partnership with the MIT Critical Data team, the workshop engaged participants in an interactive Prompt-a-Thon to explore first-hand the potential benefits, biases, and harms related to the use of Large Language Model chatbots in mental health care. This Perspective reports on five principles of digital psychiatry deployment that the workshop participants determined to be the most essential: ensuring accuracy, remaining human-centric, promoting just access, protecting privacy, and providing transparency. We place these five principles within a “Neurotech Justice” framework and discuss how guardrails can be built to promote neurotech justice in digital psychiatry.
- 8 April 2026
- Published by Springer Nature in NPP—Digital Psychiatry and Neuroscience
- Vol. 4 (1) , 7
Open AccessAdvancing neurotech justice in youth digital mental health: insights from an interdisciplinary and cross-generational workshop
Researchers and clinicians are increasingly looking to leverage artificial intelligence (AI) and digital tools to improve psychiatric care. Of particular promise is addressing the youth mental health crisis. Yet, the introduction of AI-enabled digital technologies for psychiatric treatment of young adults raises a host of ethical, legal, and societal issues (ELSI). To provide guidance in addressing these issues, we convened a two-day meeting at the Radcliffe Institute for Advanced Study at Harvard University: Advancing Neurotech Justice in Mental Health: Insights from an Interdisciplinary and Cross-Generational Workshop . The meeting brought together a diverse cohort of 17 experts and 5 students from various fields and different countries. In partnership with the MIT Critical Data team, the workshop engaged participants in an interactive Prompt-a-Thon to explore first-hand the potential benefits, biases, and harms related to the use of Large Language Model chatbots in mental health care. This Perspective reports on five principles of digital psychiatry deployment that the workshop participants determined to be the most essential: ensuring accuracy, remaining human-centric, promoting just access, protecting privacy, and providing transparency. We place these five principles within a “Neurotech Justice” framework and discuss how guardrails can be built to promote neurotech justice in digital psychiatry.
- 1 March 2026
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 26 (6) , 583-601
A Systematic Review of the Mechanistic Effects of Ginsenosides on Enhancing Radiotherapy and Providing Radioprotection
Introduction/Objective: Radiotherapy (RT) is a standard cancer treatment that may be associated with problems such as ineffectiveness and side effects. This study investigated ginsenosides' radiosensitizing and radioprotective properties and their metabolites during RT. Methods: This study searched databases including PubMed/MEDLINE, Scopus, Embase, and Cochrane Library for articles before January 28, 2025. After specifying the inclusion and exclusion criteria, relevant articles were imported into EndNote software and screened. Then, the data were recorded in tables and analyzed. Results: After the screening process, 28 articles were included. Ginsenosides exhibited radioprotective effects in normal tissues by reducing oxidative stress, preserving mitochondrial integrity, enhancing DNA repair, modulating inflammatory pathways, and supporting hematopoiesis. Key compounds such as Rg1, Rg3, and Rh2 promoted tissue regeneration and protected against radiation-induced organ damage. In tumour cells, ginsenosides enhance radiosensitivity by increasing reactive oxygen species (ROS), disrupting mitochondrial function, inducing DNA damage and cell cycle arrest, and promoting apoptosis. They also inhibited tumour progression via nuclear factor kappa B (NF-κB) suppression and immune activation, reducing angiogenesis and metastasis. These dual actions suggest their potential to improve radiotherapy outcomes. Discussion: Ginsenosides revealed dual roles as radioprotective and radiosensitizing agents, highlighting their potential in improving RT outcomes. However, the limited clinical data and lack of ginseng extract studies indicate the need for future clinical studies to establish optimal dosing, safety, and relevance for humans. Conclusion: The findings of both in vivo and in vitro studies indicated that ginsenosides enhance RT and provide protective effects against the harmful impacts of ionizing radiation.
- 1 March 2026
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 26 (6) , 583-601
A Systematic Review of the Mechanistic Effects of Ginsenosides on Enhancing Radiotherapy and Providing Radioprotection
Introduction/Objective: Radiotherapy (RT) is a standard cancer treatment that may be associated with problems such as ineffectiveness and side effects. This study investigated ginsenosides' radiosensitizing and radioprotective properties and their metabolites during RT. Methods: This study searched databases including PubMed/MEDLINE, Scopus, Embase, and Cochrane Library for articles before January 28, 2025. After specifying the inclusion and exclusion criteria, relevant articles were imported into EndNote software and screened. Then, the data were recorded in tables and analyzed. Results: After the screening process, 28 articles were included. Ginsenosides exhibited radioprotective effects in normal tissues by reducing oxidative stress, preserving mitochondrial integrity, enhancing DNA repair, modulating inflammatory pathways, and supporting hematopoiesis. Key compounds such as Rg1, Rg3, and Rh2 promoted tissue regeneration and protected against radiation-induced organ damage. In tumour cells, ginsenosides enhance radiosensitivity by increasing reactive oxygen species (ROS), disrupting mitochondrial function, inducing DNA damage and cell cycle arrest, and promoting apoptosis. They also inhibited tumour progression via nuclear factor kappa B (NF-κB) suppression and immune activation, reducing angiogenesis and metastasis. These dual actions suggest their potential to improve radiotherapy outcomes. Discussion: Ginsenosides revealed dual roles as radioprotective and radiosensitizing agents, highlighting their potential in improving RT outcomes. However, the limited clinical data and lack of ginseng extract studies indicate the need for future clinical studies to establish optimal dosing, safety, and relevance for humans. Conclusion: The findings of both in vivo and in vitro studies indicated that ginsenosides enhance RT and provide protective effects against the harmful impacts of ionizing radiation.
- 1 August 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (8) , e240172
Imaging of Premalignant Conditions of Bone and Soft Tissue
Imaging is important for early detection of malignant transformation and management of premalignant bone and soft-tissue conditions.
- 1 August 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (8) , e240172
Imaging of Premalignant Conditions of Bone and Soft Tissue
Imaging is important for early detection of malignant transformation and management of premalignant bone and soft-tissue conditions.
- Open Access
- 29 June 2023
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 15 (2) , 86-92
The relationship of myocardial and liver T2* values with cardiac function and laboratory findings in transfusion-dependent thalassemia major patients: A retrospective cardiac MRI study
Introduction: Cardiac complications are the leading cause of death in thalassemia patients. It is assumed that progressive iron accumulation results in myocyte damage. Myocardial T2* measurement by cardiac MRI quantifies iron overload. We aimed to study the association between left and right ventricular (LV and RV) function and iron deposition estimation by cardiac MRI T2* in a sample of Iranian patients. Methods: Cardiac MRI exams of 118 transfusion-dependent thalassemia major patients were evaluated retrospectively. Biventricular function and volume and myocardial and liver T2* values were measured. The demographic and lab data were registered. Poisson and chi-square regression analyses investigated the correlation between the T2* value and ventricular dysfunction. Results: The study participants’ mean (SD) age was 32.7y (9.02), and 47.46% were female. Forty-nine cases (41.52%) revealed at least uni-ventricular dysfunction. LV dysfunction was noted in 20 cases, whereas 47 patients revealed RV dysfunction. The risk of LV dysfunction was 5.3-fold higher in patients with cardiac T2* value less than 10msec (RR=5.3, 95% CI=1.6, 17.1, P<0.05). No association was found between age, liver T2* value, serum ferritin level, and chelation therapy with the risk of LV and RV dysfunction. Conclusion: Cardiac MRI T2* measure is a good indicator of LV dysfunction. Moreover, MRI parameters, especially RV functional measures, may have a substantial role in patient management. Therefore, cardiac MRI should be included in beta-thalassemia patients’ management strategies.
- 29 June 2023
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 15 (2) , 86-92
Open AccessThe relationship of myocardial and liver T2* values with cardiac function and laboratory findings in transfusion-dependent thalassemia major patients: A retrospective cardiac MRI study
Introduction: Cardiac complications are the leading cause of death in thalassemia patients. It is assumed that progressive iron accumulation results in myocyte damage. Myocardial T2* measurement by cardiac MRI quantifies iron overload. We aimed to study the association between left and right ventricular (LV and RV) function and iron deposition estimation by cardiac MRI T2* in a sample of Iranian patients. Methods: Cardiac MRI exams of 118 transfusion-dependent thalassemia major patients were evaluated retrospectively. Biventricular function and volume and myocardial and liver T2* values were measured. The demographic and lab data were registered. Poisson and chi-square regression analyses investigated the correlation between the T2* value and ventricular dysfunction. Results: The study participants’ mean (SD) age was 32.7y (9.02), and 47.46% were female. Forty-nine cases (41.52%) revealed at least uni-ventricular dysfunction. LV dysfunction was noted in 20 cases, whereas 47 patients revealed RV dysfunction. The risk of LV dysfunction was 5.3-fold higher in patients with cardiac T2* value less than 10msec (RR=5.3, 95% CI=1.6, 17.1, P<0.05). No association was found between age, liver T2* value, serum ferritin level, and chelation therapy with the risk of LV and RV dysfunction. Conclusion: Cardiac MRI T2* measure is a good indicator of LV dysfunction. Moreover, MRI parameters, especially RV functional measures, may have a substantial role in patient management. Therefore, cardiac MRI should be included in beta-thalassemia patients’ management strategies.
- Open Access
- 12 November 2022
- Published by International Society of Global Health in Journal of Global Health
- Vol. 12, 05048
In-hospital mortality of COVID-19 in Iranian children and youth: A multi-centre retrospective cohort study
A respiratory syndrome caused by coronavirus 2019 (SARS-CoV-2) was first introduced in Wuhan, China, in 2019 and soon after became a global pandemic known as COVID-19. COVID-19 is lethal among all age groups. However, it causes less severe diseases among children and young people [1]. The global average age of the COVID-19 infected patients is […]
- 12 November 2022
- Published by International Society of Global Health in Journal of Global Health
- Vol. 12, 05048
Open AccessIn-hospital mortality of COVID-19 in Iranian children and youth: A multi-centre retrospective cohort study
A respiratory syndrome caused by coronavirus 2019 (SARS-CoV-2) was first introduced in Wuhan, China, in 2019 and soon after became a global pandemic known as COVID-19. COVID-19 is lethal among all age groups. However, it causes less severe diseases among children and young people [1]. The global average age of the COVID-19 infected patients is […]